# Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis

> **NCT00637780** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 2 (actual)

## Conditions studied

- Arthritis, Juvenile Rheumatoid

## Interventions

- **DRUG:** Sulfasalazine

## Key facts

- **NCT ID:** NCT00637780
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study terminated on 13 April 2016 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637780, "Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00637780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*